Digestive Diseases and Sciences

, Volume 59, Issue 9, pp 2222–2227 | Cite as

The Prevalence of Clostridium difficile Infection in Pediatric and Adult Patients with Inflammatory Bowel Disease

  • S. K. HouriganEmail author
  • M. Oliva-Hemker
  • S. Hutfless
Original Article



Adults with inflammatory bowel disease (IBD) have a high prevalence of Clostridium difficile infection (CDI). CDI in children with IBD may differ from adults. We aim to compare the prevalence of CDI in hospitalized pediatric and adult IBD patients and patients without IBD.


The rates of CDI per 1,000 IBD and non-IBD hospitalizations between 1993 and 2012 were examined using the Maryland Health Services Cost Review Commission database. Age, sex and calendar year adjusted incidence rate ratios comparing CDI in pediatrics and adults by type of IBD and with patients without IBD were calculated. p values for trend identifying changes in rates over time were calculated.


Among children, the rate of CDI was over 12 times greater in IBD than non-IBD hospitalizations (p < 0.0001) and among adults, the rate of CDI was four times greater in IBD than non-IBD hospitalizations (p < 0.0001). In adults, CDI was significantly higher in ulcerative colitis (UC) than Crohn’s disease (60.4 per 1,000 vs. 19.8 per 1,000, p < 0.0001) but in children there was no difference in CDI in UC compared with Crohn’s disease (32 per 1,000 vs. 27 per 1,000, p = 0.45). The prevalence of CDI increased in pediatric and adult IBD patients, and patients without IBD, between 1993 and 2012 (p for trend <0.0001).


CDI was more common in adult patients with UC, and no difference was found between CDI and IBD type in pediatrics. There may be different risk factors for CDI during hospitalization between adults and children with IBD.


Inflammatory bowel disease Clostridium difficile Pediatric 


Conflict of interest



  1. 1.
    Ananthakrishnan AN. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol. 2011;8:17–26.PubMedCrossRefGoogle Scholar
  2. 2.
    Sammons JS, Toltzis P. Recent trends in the epidemiology and treatment of C. difficile infection in children. Curr Opin Pediatr. 2013;25:116–121.PubMedCrossRefGoogle Scholar
  3. 3.
    Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med. 2006;145:758–764.PubMedCrossRefGoogle Scholar
  4. 4.
    Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998;40:1–15.PubMedCrossRefGoogle Scholar
  5. 5.
    Rodemann JF, Dubberke ER, Reske KA, et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:339–344.PubMedCrossRefGoogle Scholar
  6. 6.
    Ananthakrishnan AN, McGinley EL, Saeian K, et al. Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:976–983.PubMedCrossRefGoogle Scholar
  7. 7.
    Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008;57:205–210.PubMedCrossRefGoogle Scholar
  8. 8.
    Jangi S, Lamont JT. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr. 2010;51:2–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Heyman MB, Kirschner BS, Gold BD, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr. 2005;146:35–40.PubMedCrossRefGoogle Scholar
  10. 10.
    Pascarella F, Martinelli M, Miele E, et al. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. J Pediatr. 2009;154:854–858.PubMedCrossRefGoogle Scholar
  11. 11.
    Kelsen JR, Kim J, Latta D, et al. Recurrence rate of Clostridium difficile infection in hospitalized pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:50–55.PubMedCrossRefGoogle Scholar
  12. 12.
    Pant C, Anderson MP, Deshpande A, et al. Health care burden of Clostridium difficile infection in hospitalized children with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:1080–1085.PubMedCrossRefGoogle Scholar
  13. 13.
    Maryland Cost Services Cost Review Commission. Overview of databases (Internet). Baltimore, MD, HSCRC.
  14. 14.
    Agarwal S, Smereka P, Harpaz N, et al. Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease. Inflamm Bowel Dis. 2011;17:251–259.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361:2033–2045.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Schutze GE, Willoughby RE; Committee on Infectious Diseases; American Academy of Pediatrics. Clostridium difficile infection in infants and children. Pediatrics. 2013;131:196–200.Google Scholar
  17. 17.
    Eglow R, Pothoulakis C, Itzkowitz S, et al. Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor. J Clin Invest. 1992;90:822–829.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Nguyen GC, Kaplan GG, Harris ML, et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:1443–1450.PubMedCrossRefGoogle Scholar
  19. 19.
    Reddy SS, Brandt LJ. Clostridium difficile infection and inflammatory bowel disease. J Clin Gastroenterol. 2013;47:666–671.PubMedCrossRefGoogle Scholar
  20. 20.
    Di Bella S, Capone A, Musso M, et al. Clostridium difficile infection in the elderly. Infez Med. 2013;21:93–102.PubMedGoogle Scholar
  21. 21.
    Pépin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171:466–472.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Toltzis P, Kim J, Dul M, et al. Presence of the epidemic North American Pulsed Field type 1 Clostridium difficile strain in hospitalized children. J Pediatr. 2009;154:607–608.PubMedCrossRefGoogle Scholar
  23. 23.
    Stamper PD, Alcabasa R, Aird D, et al. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol. 2009;47:373.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Longtin Y, Trottier S, Brochu G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis. 2013;56:67.PubMedCrossRefGoogle Scholar
  25. 25.
    Mezoff E, Mann EA, Hart KW, et al. Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population. J Pediatr Gastroenterol Nutr. 2011;52:437–441.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Berg AM, Kelly CP, Farraye FA. Clostridium difficile infection in the inflammatory bowel disease patient. Inflamm Bowel Dis. 2013;19:194–204.PubMedCrossRefGoogle Scholar
  27. 27.
    Scheurer DB, Hicks LS, et al. Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort. Epidemiol Infect. 2007;135:1010–1013.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Dubberke ER, Reske KA, McDonald LC, et al. ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis. 2006;12:1576–1579.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Clayton EM, Rea MC, Shanahan F, et al. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol. 2009;104:1162–1169.PubMedCrossRefGoogle Scholar
  30. 30.
    Hourigan SK, Chirumamilla SR, Ross T, et al. Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:2744–2752.PubMedCrossRefGoogle Scholar
  31. 31.
    Guerrerio AL, Frischmeyer-Guerrerio PA, Lederman HM, Oliva-Hemker M. Recognizing gastrointestinal and hepatic manifestations of primary immunodeficiency diseases. J Pediatr Gastroenterol Nutr. 2010;51:548–555.PubMedCrossRefGoogle Scholar
  32. 32.
    Centers for Disease Control and Prevention. Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep. 2012;61:157–162.Google Scholar
  33. 33.
    Sonnenberg A. Similar geographic variations of mortality and hospitalization associated with IBD and Clostridium difficile colitis. Inflamm Bowel Dis. 2010;16:487–493.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • S. K. Hourigan
    • 1
    • 2
    Email author
  • M. Oliva-Hemker
    • 1
  • S. Hutfless
    • 3
  1. 1.Division of Pediatric Gastroenterology and NutritionJohns Hopkins School of MedicineBaltimoreUSA
  2. 2.Pediatric Gastroenterology, Hepatology and NutritionPediatric Specialists of VirginiaFairfaxUSA
  3. 3.Division of GastroenterologyJohns Hopkins School of MedicineBaltimoreUSA

Personalised recommendations